Examining the Anti-inflammatory and Renoprotective Effects Resulting from Parasympathetic Nerve Stimulation after Inflammation

Background: Recent reports have indicated that pre-injury stimulation of the parasympathetic nervous system, activating the cholinergic anti-inflammatory pathway (CAP), yields anti-inflammatory and renoprotective effects. However, it is unclear whether similar effects can be achieved with post-injury stimulation of the parasympathetic nervous system. This study aims to confirm whether post-inflammatory stimulation of the parasympathetic nervous system can indeed lead to anti-inflammatory and renoprotective effects, as well as to elucidate the underlying mechanisms. Methods: The animal model employed in this study involved inducing acute kidney injury/sepsis using lipopolysaccharide (LPS). Due to concerns about the highly invasive nature of direct vagus nerve stimulation, we chose to activate the parasympathetic nervous system by administering 3-(2,4-Dimethoxybenzylidene)-anabaseine dihydrochloride (GTS-21), a selective α7 nicotinic acetylcholine receptor agonist. After inducing inflammation in wild-type C57BL/6 mice by administering LPS, we subsequently administered GTS-21 to evaluate its anti-inflammatory and renal protective effects. Furthermore, we induced inflammation in RAW 264 (mouse macrophages) and U937 (human macrophages) using LPS, followed by parasympathetic nerve stimulation, to evaluate their anti-inflammatory effects similarly. Furthermore, we conducted RNA-seq analyses on each cell type to elucidate the underlying molecular mechanisms. Results: We confirmed that administering the selective α7 nicotinic acetylcholine receptor agonist, GTS-21, in the mouse model of acute kidney injury/sepsis induced by LPS, resulted in anti-inflammatory and renal protective effects. Moreover, based on the findings from RNA-Seq analysis, we elucidated that the expression of CCL2, a chemokine, in splenic macrophages is involved in mediating these effects. Conclusion: Even after inflammation induction, stimulation of the parasympathetic nervous system yielded anti-inflammatory and renoprotective effects. This discovery holds significant promise for the development of novel treatments for sepsis and AKI.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.2024zeng6m6h
Primary Topic
Vagus Nerve Stimulation Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Examining the Anti-inflammatory and Renoprotective Effects Resulting from Parasympathetic Nerve Stimulation after Inflammation

Sayumi Matsuo, Norito Washimine, Chia-Hsien Wu, Yasuna Nakamura et al.
Journal of the American Society of Nephrology
Vagus Nerve Stimulation Research
article

Examining the Anti-inflammatory and Renoprotective Effects Resulting from Parasympathetic Nerve Stimulation after Inflammation

Sayumi Matsuo, Norito Washimine, Chia-Hsien Wu, Yasuna Nakamura, Tsuyoshi Inoue, Tomoya Nishino, Ryusuke Umene
article en

Abstract

Background: Recent reports have indicated that pre-injury stimulation of the parasympathetic nervous system, activating the cholinergic anti-inflammatory pathway (CAP), yields anti-inflammatory and renoprotective effects. However, it is unclear whether similar effects can be achieved with post-injury stimulation of the parasympathetic nervous system. This study aims to confirm whether post-inflammatory stimulation of the parasympathetic nervous system can indeed lead to anti-inflammatory and renoprotective effects, as well as to elucidate the underlying mechanisms. Methods: The animal model employed in this study involved inducing acute kidney injury/sepsis using lipopolysaccharide (LPS). Due to concerns about the highly invasive nature of direct vagus nerve stimulation, we chose to activate the parasympathetic nervous system by administering 3-(2,4-Dimethoxybenzylidene)-anabaseine dihydrochloride (GTS-21), a selective α7 nicotinic acetylcholine receptor agonist. After inducing inflammation in wild-type C57BL/6 mice by administering LPS, we subsequently administered GTS-21 to evaluate its anti-inflammatory and renal protective effects. Furthermore, we induced inflammation in RAW 264 (mouse macrophages) and U937 (human macrophages) using LPS, followed by parasympathetic nerve stimulation, to evaluate their anti-inflammatory effects similarly. Furthermore, we conducted RNA-seq analyses on each cell type to elucidate the underlying molecular mechanisms. Results: We confirmed that administering the selective α7 nicotinic acetylcholine receptor agonist, GTS-21, in the mouse model of acute kidney injury/sepsis induced by LPS, resulted in anti-inflammatory and renal protective effects. Moreover, based on the findings from RNA-Seq analysis, we elucidated that the expression of CCL2, a chemokine, in splenic macrophages is involved in mediating these effects. Conclusion: Even after inflammation induction, stimulation of the parasympathetic nervous system yielded anti-inflammatory and renoprotective effects. This discovery holds significant promise for the development of novel treatments for sepsis and AKI.

Journal of the American Society of NephrologyVol. 35(10S)
Nagasaki Institute of Applied Science (JP)
Openalex Percentile: Top 79%
Vagus Nerve Stimulation Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.